TRANSGENOMIC LabsTRANSGENOMIC Pharmacogenomic Services TRANSGENOMIC Corporate Site

Test Catalog

MITOCHONDRIAL GENOME DISORDERS
MITO-WGA Whole Mitochondrial Genome Analysis with Haplotyping
MITO-PT-DEL mtDNA Disorder Point Mutation and Deletion Assay
MITO-DEL mtDNA Deletion Assay (CPEO, KSS, Maternally Inherited Deafness, Pearson’s Syndrome)
MITO-COPY Mitochondrial Copy Number
CYTB Cytochrome b (MTCYB)
RCD Reversible Cox Deficiency
DFNS Deafness, Aminoglycoside-Induced Nonsyndromic Deafness
LHON Leber’s Hereditary Optic Neuropathy
MELAS Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes
MERRF Myoclonus Epilepsy with Ragged Red Fibers
NARP Neurogenic Weakness, Ataxia, Retinitis Pigmentosa and Leigh’s Syndrome
NUCLEAR MITOCHONDRIAL DISORDERS
NUCLEAR-MITOME Comprehensive Sequence Analysis of >400 Nuclear Mitochondrial Genes
POLG POLG-Related Disorders: PEO, Alper’s Syndrome, Parkinsonism, Juvenile SCAE and SANDO
POLG2 POLG2-Related Disorders
SLC25A4 Autosomal Dominant Progressive External Ophthalmoplegia
C10orf2 Autosomal Dominant Progressive External Ophthalmoplegia (TWINKLE or PEO1)
AD-PEO PANEL POLG, SLC25A4, C10orf2
TYMP MNGIE Syndrome (Mito-Neurogastrointestinal Encephalomyopathy)
COMPLEX I PANEL NDUFA1, NDUFA2, NDUFA7, NDUFAF2, NDUFAF3, NDUFAF4, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2
BCS1L Complex III Deficiency – Bjornstad Syndrome, GRACILE Syndrome
COMPLEX IV PANEL Complex IV Deficiency Panel – (COX10, SCO1, SCO2, SURF1)
DGUOK mtDNA Depletion Syndrome – Hepatocerebral Form
MPV17 mtDNA Depletion Syndrome – Infantile Hepatic Form
TK2 mtDNA Depletion Syndrome – Myopathic Form
MITO-DEP Mitochondrial Depletion Syndrome, Hepatocerebral Form, Panel (MPV17, DGUOK, POLG1)
MITO-DEP/DEL Mitochondrial Depletion Syndrome and Multiple Deletion Panel (POLG1, TK2, DGUOK)
EPILEPSY AND SEIZURE-RELATED DISORDERS
FSP Febrile Seizure Panel (SCN1A, SCN1B, SCN2A, GABRD, GABRG2 and Large Del/Dup analysis of SCN1A)
FFSP Female Febrile Seizure Panel (Febrile Seizure panel plus sequencing of PCDH19)
SCN1A Sequencing - GEFS+, Dravet Syndrome
SCN1A-DEL/DUP Large Scale Deletion/Duplication Detection
SCN1A-REF SCN1A Sequencing reflexes to SCN1A Deletion/Duplication Analysis
SCN1A-COM SCN1A and SCN1A Deletion/Duplication run in parallel
SCN1B GEFS+, Dravet Syndrome
SCN2A GEFS+, Dravet Syndrome
GABRD GEFS+, Dravet Syndrome
GABRG2 GEFS+, Dravet Syndrome
PCDH19 Epilepsy limited to females with mental retardation
CHROMOSOMAL ANALYSIS
KARYO Karyotyping
CMA-180K Microarray Chip-180K
OTHER TESTS
CPT2 CPT2 Deficiency
OPA1 Optic Atrophy Type 1
VLCAD VLCAD Deficiency
CDKL5 Autism, Rett Syndrome
MECP2 Sequencing
MECP2-DEL/DUP Large Scale Deletion/Duplication Analysis
MECP2-REF MECP2 Sequencing reflexes to MECP2 Deletion/Duplication Analysis
MECP2-COM Sequencing and Deletion/Duplication run in parallel
BDNF Brain-Derived Neurotrophic Factor (BDNF) Epilepsy
PTEN Autism
UBE3A Angelman Syndrome
FRAGX-M Fragile X Syndrome (FMR1; Male)
FRAGX-F Fragile X Syndrome (FMR1; Female)
NOONAN Noonan Syndrome (PTPN11, RAF1, SOS1, KRAS)
LPIN1  Autosomal Recessive Recurrent Myoglobinuria
PWS Prader-Willi Syndrome
ONCOLOGY
KIT Exons 8 through 17
KIT 1 Tier 1 (Exons 8, 9, 11, 13, 17)
KIT 2 Tier 2 (Exons 10, 12, 14, 15, 16)
KRAS KRAS
PIK3CA  Exons 9 and 20
P53 P53
PTEN PTEN
VHL Von Hippel-Lindau Cancer Syndrome
Contact WebmasterSend Page To ColleaguePrintable Page
Copyright © 1997-2012 Transgenomic, Inc., All Rights Reserved.the power of discovery®